Oxford start-up seeks financing for stomach cancer breath test
This article was originally published in Clinica
UK start-up Oxford Micro Medical is looking to raise £100,000 ($150,000) from external investors to help advance the development of its handheld, point-of-care breathalyzer for diagnosing stomach cancer. The device, called NanoBreath, will incorporate mass spectrometry technology originally intended for use in space exploration and the finished product will be significantly cheaper, more compact and simpler to use than current instrumentation used in breath tests for stomach cancer.
Register for our free email digests: